Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 USD | +4.17% | -4.89% | -13.37% |
Mar. 13 | Transcript : Aadi Bioscience, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
Mar. 13 | Earnings Flash (AADI) AADI BIOSCIENCE Posts Q4 Revenue $6.3M | MT |
Business Summary
Number of employees: 89
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Proprietary Therapeutics
100.0
%
| 15 | 100.0 % | 24 | 100.0 % | +60.06% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 15 | 100.0 % | 24 | 100.0 % | +60.06% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Lennon
CEO | Chief Executive Officer | 53 | 23-10-01 |
Scott Giacobello
DFI | Director of Finance/CFO | 54 | 21-11-27 |
Neil Desai
CHM | Chairman | 59 | 11-09-30 |
Berta Grigorian
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Loretta Itri
CTO | Chief Tech/Sci/R&D Officer | 74 | 21-10-24 |
Marcy Graham
IRC | Investor Relations Contact | 57 | 22-04-30 |
Raymond Steitz
HRO | Human Resources Officer | - | 22-05-31 |
Andrew Kwon
PRN | Corporate Officer/Principal | - | 18-12-31 |
Bryan Ball
PRN | Corporate Officer/Principal | 54 | 22-07-31 |
Stephen M. Rodin
LAW | General Counsel | 47 | 22-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anupam Dalal
BRD | Director/Board Member | 52 | 21-08-25 |
Caley Castelein
CHM | Chairman | 53 | 21-08-25 |
Director/Board Member | 52 | 21-08-25 | |
Director/Board Member | 69 | 21-08-25 | |
Emma Reeve
BRD | Director/Board Member | 63 | 21-09-07 |
Mohammad Hirmand
BRD | Director/Board Member | 54 | 23-03-26 |
Neil Desai
CHM | Chairman | 59 | 11-09-30 |
Behzad Aghazadeh
BRD | Director/Board Member | 52 | 21-08-25 |
David Lennon
CEO | Chief Executive Officer | 53 | 23-10-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,554,205 | 19,866,312 ( 80.91 %) | 0 | 80.91 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.37% | 41.25M | |
-4.66% | 87.53B | |
+1.32% | 40.42B | |
-19.07% | 29.48B | |
+57.86% | 25.43B | |
-17.71% | 11.49B | |
-43.00% | 11.3B | |
-9.14% | 11.1B | |
+5.24% | 8.75B | |
-8.42% | 7.99B |
- Stock Market
- Equities
- AADI Stock
- Company Aadi Bioscience, Inc.